Sulfagenix Overview

  • Founded
  • 2011
  • Status
  • Private
  • Latest Deal Type
  • Series A1
  • Latest Deal Amount
  • $1.35M
Latest Deal Amount

Sulfagenix General Information


Provider of novel therapeutic molecules. The company focuses on modifying existing molecules to improve safety, bioavailability and efficacy for new uses. SG1002 (sodium polysulthionate), the company's lead molecule, is a precursor to a natural-occurring molecule, hydrogen sulfide, for which deficits have been shown to exist in a number of serious diseases, including cardiovascular disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Industries
Specialty Chemicals
Primary Office
  • 7515 Cedar Road
  • Chesterland, OH 44026
  • United States
+1 (318) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sulfagenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 27-Dec-2016 $1.35M 00.000 Completed Startup
1. Early Stage VC (Series A) 31-Mar-2014 00.00 00.00 000.00 Completed Startup
To view Sulfagenix’s complete valuation and funding history, request access »

Sulfagenix Cap Table

Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00 00 00 00 00.00
To view Sulfagenix’s complete cap table history, request access »

Sulfagenix Executive Team (5)

Name Title Board Seat Contact Info
Gabriel Gojon Ph.D Co-Founder, Chief Technology Officer & Board Member
Cesar Vidales Chief Business Officer
Anthony Giordano Ph.D Co-Founder, President & Chief Executive Officer
David Kronlage Chief Development Officer
To view Sulfagenix’s complete executive team members history, request access »

Sulfagenix Board Members (4)

Name Representing Role Since
Eduardo Cavazos Sulfagenix Chairman 000 0000
Gabriel Gojon Ph.D Sulfagenix Co-Founder, Chief Technology Officer & Board Member 000 0000
Jacobo Kleiman Ph.D Self Board Member 000 0000
Jorge Salinas Self Board Member 000 0000
To view Sulfagenix’s complete board members history, request access »